Collier, SigridSemeere, AggreyByakwaga, HelenLaker-Oketta, MiriamChemtai, LindaWagner, Anjuli D.Bassett, Ingrid V.Wools-Kaloustian, KaraMaurer, TobyMartin, JeffreyKiprono, SamsonFreeman, Esther E.2024-04-242024-04-242022-05-13Collier, S., Semeere, A., Byakwaga, H., Laker-Oketta, M., Chemtai, L., Wagner, A. D., Bassett, I. V., Wools-Kaloustian, K., Maurer, T., Martin, J., Kiprono, S., & Freeman, E. E. (2022). A type III effectiveness-implementation hybrid evaluation of a multicomponent patient navigation strategy for advanced-stage Kaposi’s sarcoma: Protocol. Implementation Science Communications, 3, 50. https://doi.org/10.1186/s43058-022-00281-7https://hdl.handle.net/1805/40204Background: For people with advanced-stage Kaposi’s sarcoma (KS), a common HIV-associated malignancy in sub-Saharan Africa, mortality is estimated to be 45% within 2 years after KS diagnosis, despite increasingly wide-spread availability of antiretroviral therapy and chemotherapy. For advanced-stage KS, chemotherapy in addition to antiretroviral therapy improves outcomes and saves lives, but currently, only ~50% of people with KS in western Kenya who have an indication for chemotherapy actually receive it. This protocol describes the evaluation of a multicomponent patient navigation strategy that addresses common barriers to service penetration of and fidelity to evidence-based chemotherapy among people with advanced-stage KS in Kenya. Methods: This is a hybrid type III effectiveness-implementation study using a non-randomized, pre- post-design nested within a longitudinal cohort. We will compare the delivery of evidence-based chemotherapy for advanced stage KS during the period before (2016–2020) to the period after (2021–2024), the rollout of a multicomponent patient navigation strategy. The multicomponent patient navigation strategy was developed in a systematic process to address key determinants of service penetration of and fidelity to chemotherapy in western Kenya and includes (1) physical navigation and care coordination, (2) video-based education, (3) travel stipend, (4) health insurance enrollment assistance, (5) health insurance stipend, and (6) peer mentorship. We will compare the pre-navigation period to the post-navigation period to assess the impact of this multicomponent patient navigation strategy on (1) implementation outcomes: service penetration (chemotherapy initiation) and fidelity (chemotherapy completion) and (2) service and client outcomes: timeliness of cancer care, mortality, quality of life, stigma, and social support. We will also describe the implementation process and the determinants of implementation success for the multicomponent patient navigation strategy. Discussion: This study addresses an urgent need for effective implementation strategies to improve the initiation and completion of evidence-based chemotherapy in advanced-stage KS. By using a clearly specified, theory-based implementation strategy and validated frameworks, this study will contribute to a more comprehensive understanding of how to improve cancer treatment in advanced-stage KS.en-USAttribution 4.0 InternationalEffectiveness-implementation hybridKaposi’s sarcomaHIV-associated malignanciesLow- and middle-income countriesArticle